{"organizations": [], "uuid": "e13913c64ed1e6f9d2b900b22691e953ddee18d5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novocure-reports-positive-top-line/brief-novocure-reports-positive-top-line-results-from-stellar-phase-2-pilot-trial-in-mesothelioma-idUSASO0003DD", "country": "US", "domain_rank": 408, "title": "BRIEF-Novocure Reports Positive Top-Line Results From Stellar Phase 2 Pilot Trial In Mesothelioma", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T17:05:00.000+03:00", "replies_count": 0, "uuid": "e13913c64ed1e6f9d2b900b22691e953ddee18d5"}, "author": "", "url": "https://www.reuters.com/article/brief-novocure-reports-positive-top-line/brief-novocure-reports-positive-top-line-results-from-stellar-phase-2-pilot-trial-in-mesothelioma-idUSASO0003DD", "ord_in_thread": 0, "title": "BRIEF-Novocure Reports Positive Top-Line Results From Stellar Phase 2 Pilot Trial In Mesothelioma", "locations": [], "entities": {"persons": [{"name": "novocure", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "pilot trial in mesothelioma reuters", "sentiment": "none"}, {"name": "novocure ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17, 2018 / 2:08 PM / Updated 30 minutes ago BRIEF-Novocure Reports Positive Top-Line Results From Stellar Phase 2 Pilot Trial In Mesothelioma Reuters Staff \nApril 17 (Reuters) - Novocure Ltd: \n* NOVOCURE REPORTS POSITIVE TOP-LINE RESULTS FROM STELLAR PHASE 2 PILOT TRIAL IN MESOTHELIOMA \n* NOVOCURE LTD - FINAL STELLAR DATA EXCEEDED RESULTS OF INTERIM ANALYSIS FOR ALL EFFICACY ENDPOINTS \n* NOVOCURE LTD - NOVOCURE PLANS TO SUBMIT A HUMANITARIAN DEVICE EXEMPTION APPLICATION TO FDA FOR APPROVAL Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-17T17:05:00.000+03:00", "crawled": "2018-04-17T17:46:08.000+03:00", "highlightTitle": ""}